Aranding, Rudy .

HRN: 05-75-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2022
CEFUROXIME 750MG (VIAL)
10/10/2022
10/17/2022
IV
1.5 G
Q8 H
Right Inguinal Hernia
Waiting Final Action 
10/10/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2022
10/17/2022
IV
500 Mg
Q8H
Right Inguinal Hernia
Waiting Final Action 
10/11/2022
CEFUROXIME 750MG (VIAL)
10/11/2022
10/18/2022
IV
750mg
Q8h
Post Hernia Repair
10/11/2022
CEFUROXIME 750MG (VIAL)
10/11/2022
10/18/2022
IV
1.5g
7 Days
Post Hernia Repair
Waiting Final Action 
10/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/11/2022
10/18/2022
IV
500mg
Q8h
Post Hernia Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: